One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Structural Biology and Molecular Modeling Techniques Market

[ 英語タイトル ] Structural Biology and Molecular Modeling Techniques Market - Growth, Trends, and Forecasts (2020 - 2025)


Product Code : MDHC0089327
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 110
Category : Healthcare and Pharmaceuticals
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
 - Acellera Ltd
- Agile Molecule
- Agilent Technologies Inc.
- Biomax Informatics AG
- Bruker Daltonics Inc.
- Chemical Computing Group
- Dassault Systemes
- Illumina
- ThermoFisher Scientific

[Report Description]

The structural biology and molecular modeling techniques market is anticipated to register a CAGR of nearly 10.4% during the forecast period.

- Certain factors that are driving the market growth include technological innovations and advancements and rising prevalence of chronic diseases.
- 3D modeling software is a powerful tool that helps many professionals create complex 3D graphics and visualize their work. In the field of structural biology and biochemistry, there are various software for molecular modeling and visualization. Some chemistry software are better in terms of drawing chemical reactions, and some others find better applications in the simulation of protein structures.

Key Market Trends

Drug Development Holds Significant Market Share in the Global Structural Biology and Molecular Modeling Techniques Market

The propelling factors for the growth of the drug discovery market include the rising prevalence of a wide range of diseases (such as cardiovascular and CNS-related disorders), rising healthcare expenditure, and upcoming patent expiration of blockbuster drugs.

The diverse range of diseases, primarily cardiovascular disease, infectious diseases, diabetes, and kidney-related complications, has a high prevalence, globally. Thus, the increasing prevalence of a diverse range of diseases among all age groups and its burden, globally, drives the demand for drug discovery and its market.

There has been an upsurge in the usage of advanced technologies, such as high throughput, bioinformatics, and combinatorial chemistry for better drug candidate identification.

North America Dominates the Global Structural Biology and Molecular Modeling Techniques Market

North America dominates the market and incurs the highest expenditure for global R&D. The United States accounted for the largest share in 2019. The North America segment is on a rise, due to various ongoing researches in biological sciences, considerable investments by various biotechnology companies, and the consistently increasing utilization of structural biology and molecular modeling techniques in the market. Owing to the ongoing research and outsourcing activities in the field of life science, Asia-Pacific also has lucrative opportunities for growth over the forecast period.

Competitive Landscape

The global structural biology and molecular modeling techniques market is competitive and consists of a number of major players. Companies, like Acellera Ltd, Agile Molecule, Agilent Technologies Inc., Biomax Informatics AG, Bruker Daltonics Inc., Chemical Computing Group, Dassault Systèmes, Illumina, and ThermoFisher Scientific, hold the substantial market share in the market.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Technological Innovations and Advancements
4.2.2 Rising Prevalence of Chronic Diseases
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Tools
5.1.1 SaaS and Standalone Modeling
5.1.1.1 Homology Modeling
5.1.1.2 Threading
5.1.1.3 Molecular Dynamics
5.1.1.4 Others
5.1.2 Visualization and Analysis
5.1.3 Other Tools
5.2 By Application
5.2.1 Drug Development
5.2.2 Drug Discovery
5.2.3 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Acellera Ltd
6.1.2 Agile Molecule
6.1.3 Agilent Technologies Inc.
6.1.4 Biomax Informatics AG
6.1.5 Bruker Daltonics Inc.
6.1.6 Chemical Computing Group
6.1.7 Dassault Systemes
6.1.8 Illumina
6.1.9 ThermoFisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+